A phase-ii study testing weekly platinum derivative combination chemotherapy as 2nd-line treatment in patients with advanced small-cell lung-cancer.
Sculier J, Thiriaux J, Bureau G, Lafitte J, Recloux P, Brohee D, Berchier M, Sergysels R, Mommen P, Paesmans M, Klastersky J, Lecomte J, Vanschaardenburg C, Richard V, Diana D, Fortin F, Tagnon A, Kustner U.
Sculier J, et al. Among authors: sergysels r.
Int J Oncol. 1995 Feb;6(2):425-9. doi: 10.3892/ijo.6.2.425.
Int J Oncol. 1995.
PMID: 21556555